We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Humana
HUM
$46.7B
| $50.3M | 0.12% |
243,771
+2,910
| +1% | +$602K |
|
177
Welltower
WELL
$172B
| $50.2M | 0.12% |
708,972
+25,271
| +4% | +$1.71M |
|
|
ATVI
178
DELISTED
Activision Blizzard
ATVI
| $49.7M | 0.12% |
996,030
+13,351
| +1% | +$587K |
|
|
DFS
179
DELISTED
Discover Financial Services
DFS
| $49.6M | 0.12% |
725,769
-8,848
| -1% | -$621K |
|
180
Cummins
CMI
$88.5B
| $49.4M | 0.12% |
326,789
-2,419
| -0.7% | -$358K |
|
181
AvalonBay Communities
AVB
$27.2B
| $49.2M | 0.11% |
267,836
+15,356
| +6% | +$2.76M |
|
182
Archer Daniels Midland
ADM
$40.1B
| $49.1M | 0.11% |
1,067,216
+36,782
| +4% | +$1.65M |
|
183
Electronic Arts
EA
$52.4B
| $49.1M | 0.11% |
548,164
+8,967
| +2% | +$763K |
|
184
Equity Residential
EQR
$25.5B
| $48.8M | 0.11% |
783,607
+49,005
| +7% | +$3.06M |
|
185
Fidelity National Information Services
FIS
$23.2B
| $48.7M | 0.11% |
611,165
-37,395
| -6% | -$3.01M |
|
186
Constellation Brands
STZ
$22.5B
| $48.4M | 0.11% |
298,346
+2,609
| +0.9% | +$407K |
|
187
Amphenol
APH
$177B
| $48.3M | 0.11% |
2,716,248
+161,668
| +6% | +$2.8M |
|
188
LyondellBasell Industries
LYB
$18.8B
| $48.2M | 0.11% |
528,942
+858
| +0.2% | +$78.3K |
|
189
Sysco
SYY
$40.7B
| $48.1M | 0.11% |
926,838
+19,935
| +2% | +$1.06M |
|
190
Sempra
SRE
$59.2B
| $47.9M | 0.11% |
867,658
-30,758
| -3% | -$1.63M |
|
191
Air Products & Chemicals
APD
$65.2B
| $47.6M | 0.11% |
352,138
+4,743
| +1% | +$669K |
|
192
Intuit
INTU
$85.6B
| $47.6M | 0.11% |
410,033
+6,252
| +2% | +$749K |
|
|
ALXN
193
DELISTED
Alexion Pharmaceuticals
ALXN
| $46.9M | 0.11% |
386,876
+10,282
| +3% | +$1.33M |
|
|
STI
194
DELISTED
SunTrust Banks, Inc.
STI
| $46.8M | 0.11% |
846,233
-47,965
| -5% | -$2.75M |
|
195
Xcel Energy
XEL
$50.1B
| $46.8M | 0.11% |
1,052,142
+97,296
| +10% | +$4.12M |
|
196
Illumina
ILMN
$29.2B
| $46.6M | 0.11% |
281,039
+4,131
| +1% | +$651K |
|
197
Marathon Petroleum
MPC
$89.3B
| $46.6M | 0.11% |
922,897
+27,848
| +3% | +$1.39M |
|
198
Ventas
VTR
$47.7B
| $46.4M | 0.11% |
713,950
+28,400
| +4% | +$1.77M |
|
199
Edison International
EIX
$30.7B
| $46.4M | 0.11% |
583,271
+17,612
| +3% | +$1.34M |
|
200
Progressive
PGR
$128B
| $46.1M | 0.11% |
1,177,465
+142,563
| +14% | +$5.44M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.